Vera Therapeutics, Inc. (VERA)
40.33
+0.33
(+0.82%)
USD |
NASDAQ |
Apr 08, 16:00
40.35
+0.02
(+0.05%)
After-Hours: 20:00
Vera Therapeutics Total Liabilities (Quarterly) : 130.78M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 301.24M |
| Syndax Pharmaceuticals, Inc. | 465.08M |
| Eli Lilly & Co. | 85.94B |
| Johnson & Johnson | 117.67B |
| United Therapeutics Corp. | 872.90M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 735.30M |
| Shareholders Equity (Quarterly) | 604.52M |
| Debt to Equity Ratio | 0.1279 |
| Current Ratio | 13.54 |
| Net Debt Paydown Yield | -0.12% |